http://www.lls.org Podcast for those living with chronic myelogenous leukemia (CML). Sponsored by The Leukemia & Lymphoma Society. admin@lls.org (admin@lls.org) en-us Tue, 21 May 2013 01:40:16 GMT Hipcast RSS Feeder 1.25 Health & Fitness 60 http://lls.hipcast.com/albumart/1003.1369100416.jpg http://www.lls.org The Leukemia & Lymphoma Society no leukemia,CML,chronic,myelogenous,leukemia Samantha Mills Samantha.Mills@lls.org f887ff1a-edff-13e1-a825-f62d76d76737 Fri, 17 May 2013 14:22:23 GMT 00:19:41 The Leukemia & Lymphoma Society Date: April 17, 2013 Speaker: Jorge Cortes, MD Topics Covered: Current treatment options for CML patients CML therapies Key elements of monitoring response to CML treatment The role of clinical trials in the advancement of CML treatment Quality of life issues for patients living with CML Communication touch points among patients and healthcare providers CML- Living with a Chronic Disease - Part 2 no CML- Living with a Chronic Disease - Part 2 Date: April 17, 2013 Speaker: Jorge Cortes, MD Topics Covered: Current treatment options for CML patients CML therapies Key elements of monitoring response to CML treatment The role of clinical trials in the advancement of CML treatment Quality of life issues for patients living with CML Communication touch points among patients and healthcare providers http://lls.hipcast.com/deluge/b9f5cbf2-36a4-cf9d-54a7-d8dc0621fac1.mp3 5a6d8ed5-3827-64ae-3758-80cc71206f20 Fri, 17 May 2013 14:20:51 GMT 00:38:42 The Leukemia & Lymphoma Society Date: April 17, 2013 Speaker: Jorge Cortes, MD Topics Covered: Current treatment options for CML patients CML therapies Key elements of monitoring response to CML treatment The role of clinical trials in the advancement of CML treatment Quality of life issues for patients living with CML Communication touch points among patients and healthcare providers CML- Living with a Chronic Disease Part 1 no CML- Living with a Chronic Disease Part 1 Date: April 17, 2013 Speaker: Jorge Cortes, MD Topics Covered: Current treatment options for CML patients CML therapies Key elements of monitoring response to CML treatment The role of clinical trials in the advancement of CML treatment Quality of life issues for patients living with CML Communication touch points among patients and healthcare providers http://lls.hipcast.com/deluge/8b4d838c-a1a4-83c4-22af-5a66cf378776.mp3 3adb7f47-84d6-e748-241e-4e8f87187925 Fri, 05 Apr 2013 20:42:53 GMT 00:40:24 The Leukemia & Lymphoma Society Date: February 26, 2013 Speaker: Stephen D. Nimer, MD Topics: Understanding goals of treatment for your diagnosis Understanding your treatment options Benefits and risks for standard treatments and investigational treatments Key facts about clinical trials Blood Cancer Treatment - Making Informed Choices - Part 1 no Blood Cancer Treatment - Making Informed Choices - Part 1 Date: February 26, 2013 Speaker: Stephen D. Nimer, MD Topics: Understanding goals of treatment for your diagnosis Understanding your treatment options Benefits and risks for standard treatments and investigational treatments Key facts about clinical trials http://lls.hipcast.com/deluge/90f6f90f-8cb8-c292-8f35-031af4837b4d.mp3 6751cd7c-d958-1e02-ce5b-85404d214db1 Fri, 05 Apr 2013 20:41:58 GMT 00:14:31 The Leukemia & Lymphoma Society Date: February 26, 2013 Speaker: Stephen D. Nimer, MD Topics: Understanding goals of treatment for your diagnosis Understanding your treatment options Benefits and risks for standard treatments and investigational treatments Key facts about clinical trials Blood Cancer Treatment - Making Informed Choices - Part 2 no Blood Cancer Treatment - Making Informed Choices - Part 2 Date: February 26, 2013 Speaker: Stephen D. Nimer, MD Topics: Understanding goals of treatment for your diagnosis Understanding your treatment options Benefits and risks for standard treatments and investigational treatments Key facts about clinical trials http://lls.hipcast.com/deluge/6fe49280-bd63-156f-1654-24aa83296fbd.mp3 a78cb39d-123c-0f91-b768-42be21caca33 Thu, 06 Dec 2012 20:26:08 GMT 00:40:46 The Leukemia & Lymphoma Society Speaker: Neil P. Shah, MD, PhD; Topics Covered: - CML treatment options in an era of multiple approved oral therapy drugs; - Discussion points between patients and their healthcare teams to help with treatment decisions; - The importance of monitoring treatment response and follow-up screenings; - Psychosocial aspects of living with a chronic cancer; - Resources to help patients manage the impact of costs associated with CML treatment CML - Diagnosis and Treatment Update Part 1 no CML - Diagnosis and Treatment Update Part 1 Speaker: Neil P. Shah, MD, PhD; Topics Covered: - CML treatment options in an era of multiple approved oral therapy drugs; - Discussion points between patients and their healthcare teams to help with treatment decisions; - The importance of monitoring treatment response and follow-up screenings; - Psychosocial aspects of living with a chronic cancer; - Resources to help patients manage the impact of costs associated with CML treatment http://lls.hipcast.com/deluge/a352a03f-f0e0-5360-7c0f-c7163d2689aa.mp3 06391ccd-f44f-6532-95cb-3a070a06faeb Thu, 06 Dec 2012 20:25:48 GMT 00:20:41 The Leukemia & Lymphoma Society Speaker: Neil P. Shah, MD, PhD; Topics Covered: - CML treatment options in an era of multiple approved oral therapy drugs; - Discussion points between patients and their healthcare teams to help with treatment decisions; - The importance of monitoring treatment response and follow-up screenings; - Psychosocial aspects of living with a chronic cancer; - Resources to help patients manage the impact of costs associated with CML treatment CML - Diagnosis and Treatment Update Part 2 no CML - Diagnosis and Treatment Update Part 2 Speaker: Neil P. Shah, MD, PhD; Topics Covered: - CML treatment options in an era of multiple approved oral therapy drugs; - Discussion points between patients and their healthcare teams to help with treatment decisions; - The importance of monitoring treatment response and follow-up screenings; - Psychosocial aspects of living with a chronic cancer; - Resources to help patients manage the impact of costs associated with CML treatment http://lls.hipcast.com/deluge/bb8e80de-c60d-1e7e-570d-d3acbc74870d.mp3 9aa7d438-a598-0b00-9648-656240db1432 Tue, 24 Apr 2012 00:59:52 GMT 00:58:01 The Leukemia & Lymphoma Society Speaker: Dr. David L. Porter; Topics Covered: Current treatment options for CML patients; Emerging therapies for CML treatment; The role of clinical trials in the advancement of CML treatment; Quality of life issues in the treatment of patients with CML CML - Updates from the ASH annual meeting Spanish no CML - Updates from the ASH annual meeting Spanish Speaker: Dr. David L. Porter; Topics Covered: Current treatment options for CML patients; Emerging therapies for CML treatment; The role of clinical trials in the advancement of CML treatment; Quality of life issues in the treatment of patients with CML http://lls.hipcast.com/deluge/d1a3f35e-31fc-4378-e257-6f5ee9785552.mp3 1f26ab94-53dd-0d3a-8f72-3eb85e041cad Mon, 27 Feb 2012 15:46:37 GMT 00:33:49 The Leukemia & Lymphoma Society Speaker: Dr. David L. Porter; Topics Covered: Current treatment options for CML patients; Emerging therapies for CML treatment; The role of clinical trials in the advancement of CML treatment; Quality of life issues in the treatment of patients with CML CML - Updates from the ASH annual meeting Part 1 no CML - Updates from the ASH annual meeting Part 1 Speaker: Dr. David L. Porter; Topics Covered: Current treatment options for CML patients; Emerging therapies for CML treatment; The role of clinical trials in the advancement of CML treatment; Quality of life issues in the treatment of patients with CML http://lls.hipcast.com/deluge/d3593fe4-f6b7-7444-757b-de5b68757cb8.mp3 df378890-d802-4821-cd82-9f7f3c1d154c Mon, 27 Feb 2012 15:46:15 GMT 00:21:31 The Leukemia & Lymphoma Society Speaker: Dr. David L. Porter; Topics Covered: Current treatment options for CML patients; Emerging therapies for CML treatment; The role of clinical trials in the advancement of CML treatment; Quality of life issues in the treatment of patients with CML CML - Updates from the ASH annual meeting Part 2 no CML - Updates from the ASH annual meeting Part 2 Speaker: Dr. David L. Porter; Topics Covered: Current treatment options for CML patients; Emerging therapies for CML treatment; The role of clinical trials in the advancement of CML treatment; Quality of life issues in the treatment of patients with CML http://lls.hipcast.com/deluge/2e7f671a-c1ce-12be-0855-7066486f9a16.mp3 84895986-365f-6864-cc90-5f82aecb4d1a Wed, 21 Dec 2011 13:11:53 GMT 00:24:17 The Leukemia & Lymphoma Society Speaker: Michael J. Mauro, MD; Topics Covered: - Current and emerging treatment options for the newly diagnosed; - Importance of monitoring treatment response; - Role of clinical trials in CML treatment; - Quality of life issues CML Expert Inform. - Diagnosis & Treatment - Part 1 Spanish no CML Expert Inform. - Diagnosis & Treatment - Part 1 Spanish Speaker: Michael J. Mauro, MD; Topics Covered: - Current and emerging treatment options for the newly diagnosed; - Importance of monitoring treatment response; - Role of clinical trials in CML treatment; - Quality of life issues http://lls.hipcast.com/deluge/765a6e70-6d01-c371-6cd9-095a32b09b05.mp3 4d1189ef-2fe8-1d22-65bd-0a249979828f Wed, 21 Dec 2011 13:11:35 GMT 00:35:12 The Leukemia & Lymphoma Society Speaker: Michael J. Mauro, MD; Topics Covered: - Current and emerging treatment options for the newly diagnosed; - Importance of monitoring treatment response; - Role of clinical trials in CML treatment; - Quality of life issues CML Expert Inform. - Diagnosis & Treatment - Part 2 Spanish no CML Expert Inform. - Diagnosis & Treatment - Part 2 Spanish Speaker: Michael J. Mauro, MD; Topics Covered: - Current and emerging treatment options for the newly diagnosed; - Importance of monitoring treatment response; - Role of clinical trials in CML treatment; - Quality of life issues http://lls.hipcast.com/deluge/ee8a11b0-3dc0-8c80-4f4e-5c3112c41c35.mp3 d7cf43d0-ec60-64af-22c9-79f2ef55cb5d Tue, 29 Nov 2011 19:40:21 GMT 00:28:38 The Leukemia & Lymphoma Society Speaker: Michael J. Mauro, MD; Topics Covered: - Current and emerging treatment options for the newly diagnosed; - Importance of monitoring treatment response; - Role of clinical trials in CML treatment; - Quality of life issues CML Expert Information About Diagnosis & Treatment - Part 2 no CML Expert Information About Diagnosis & Treatment - Part 2 Speaker: Michael J. Mauro, MD; Topics Covered: - Current and emerging treatment options for the newly diagnosed; - Importance of monitoring treatment response; - Role of clinical trials in CML treatment; - Quality of life issues http://lls.hipcast.com/deluge/6601b67f-cdb2-40e7-bbbd-5cde525154ff.mp3 b57f3160-0551-534f-82e5-17939d567115 Tue, 29 Nov 2011 19:35:17 GMT 00:18:58 The Leukemia & Lymphoma Society Speaker: Michael J. Mauro, MD; Topics Covered: - Current and emerging treatment options for the newly diagnosed; - Importance of monitoring treatment response; - Role of clinical trials in CML treatment; - Quality of life issues CML Expert Information About Diagnosis & Treatment - Part 1 no CML Expert Information About Diagnosis & Treatment - Part 1 Speaker: Michael J. Mauro, MD; Topics Covered: - Current and emerging treatment options for the newly diagnosed; - Importance of monitoring treatment response; - Role of clinical trials in CML treatment; - Quality of life issues http://lls.hipcast.com/deluge/e75ea36e-b512-d23f-3f82-53d5c62e454f.mp3 128c62e4-c38c-21c6-5035-8cf74f8fd46e Tue, 09 Aug 2011 19:55:36 GMT 00:22:45 The Leukemia & Lymphoma Society Part II of Dr. Cortes discusses treating CML, focuses on therapy for newly diagnosed patients and answers audience questions. CML Information for the Newly Diagnosed Part II Spanish no CML Information for the Newly Diagnosed Part II Spanish Part II of Dr. Cortes discusses treating CML, focuses on therapy for newly diagnosed patients and answers audience questions. http://lls.hipcast.com/deluge/fe5c509b-2527-ed6c-9e0e-1d5cce20a0c5.mp3 3cfca421-2d29-c97b-f715-9e5a9a62d068 Tue, 09 Aug 2011 19:55:15 GMT 00:33:23 The Leukemia & Lymphoma Society Dr. Cortes discusses treating CML, focuses on therapy for newly diagnosed patients and answers audience questions. CML Information for the Newly Diagnosed Part I Spanish no CML Information for the Newly Diagnosed Part I Spanish Dr. Cortes discusses treating CML, focuses on therapy for newly diagnosed patients and answers audience questions. http://lls.hipcast.com/deluge/cb5092b8-dd6b-9dc1-e841-fbeedd1f37ea.mp3 90224c3b-ba8a-1f54-cf2f-65073436803e Wed, 26 Jan 2011 16:44:05 GMT 00:13:16 The Leukemia & Lymphoma Society December 14, 2010 - Part 2 (Q&A) CML: What's New from the American Society of Hematology (ASH) Annual Meeting This program featured Neil P. Shah, MD, PhD, Assistant Professor, Division of Hematology/Oncology, Department of Medicine, University of California San Francisco (UCSF) School of Medicine, Co-Leader, Hematopoietic Malignancies Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. This program was sponsored by The Leukemia & Lymphoma Society and was supported by grants from Bristol-Myers Squibb and Novartis Oncology. Program Slides: http://www.lls.org/graphics/National/ShahSlidesFinal121410.pdf Transcript: http://www.lls.org/graphics/National/0210330TL2CMLTranscriptoldlogo.pdf CML: What's New from the ASH Annual Meeting - Part 2 no CML: What's New from the ASH Annual Meeting - Part 2 December 14, 2010 - Part 2 (Q&A) CML: What's New from the American Society of Hematology (ASH) Annual Meeting This program featured Neil P. Shah, MD, PhD, Assistant Professor, Division of Hematology/Oncology, Department of Medicine, University of California San Francisco (UCSF) School of Medicine, Co-Leader, Hematopoietic Malignancies Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. This program was sponsored by The Leukemia & Lymphoma Society and was supported by grants from Bristol-Myers Squibb and Novartis Oncology. Program Slides: http://www.lls.org/graphics/National/ShahSlidesFinal121410.pdf Transcript: http://www.lls.org/graphics/National/0210330TL2CMLTranscriptoldlogo.pdf http://lls.hipcast.com/deluge/7876e463-f5df-f53f-4bf1-f042d99b7023.mp3 db43a927-b625-298e-98e9-95445c8bb34b Wed, 26 Jan 2011 16:43:20 GMT 00:39:37 The Leukemia & Lymphoma Society December 14, 2010 - Part 1 (Presentation) CML: What's New from the American Society of Hematology (ASH) Annual Meeting This program featured Neil P. Shah, MD, PhD, Assistant Professor, Division of Hematology/Oncology, Department of Medicine, University of California San Francisco (UCSF) School of Medicine, Co-Leader, Hematopoietic Malignancies Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. This program was sponsored by The Leukemia & Lymphoma Society and was supported by grants from Bristol-Myers Squibb and Novartis Oncology. Program Slides: http://www.lls.org/graphics/National/ShahSlidesFinal121410.pdf Transcript: http://www.lls.org/graphics/National/0210330TL2CMLTranscriptoldlogo.pdf CML: What's New from the ASH Annual Meeting - Part 1 no CML: What's New from the ASH Annual Meeting - Part 1 December 14, 2010 - Part 1 (Presentation) CML: What's New from the American Society of Hematology (ASH) Annual Meeting This program featured Neil P. Shah, MD, PhD, Assistant Professor, Division of Hematology/Oncology, Department of Medicine, University of California San Francisco (UCSF) School of Medicine, Co-Leader, Hematopoietic Malignancies Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. This program was sponsored by The Leukemia & Lymphoma Society and was supported by grants from Bristol-Myers Squibb and Novartis Oncology. Program Slides: http://www.lls.org/graphics/National/ShahSlidesFinal121410.pdf Transcript: http://www.lls.org/graphics/National/0210330TL2CMLTranscriptoldlogo.pdf http://lls.hipcast.com/deluge/b4631306-5854-383e-2f66-b0aef0a75dec.mp3 928028fc-9491-0e67-4fea-a71323fdc7ff Fri, 05 Nov 2010 14:55:50 GMT 00:20:25 The Leukemia & Lymphoma Society October 19, 2010 CML Information for the Newly Diagnosed - Part 2 (Q&A) This program featured Jorge Cortes, MD, D.B. Lane Cancer Research Distinguished Professor for Leukemia Research, Deputy Chairman, Section Chief of AML & CML, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston TX. This program was sponsored by The Leukemia & Lymphoma Society and was supported by grants from Novartis Oncology and Bristol-Myers Squibb. Program slides: http://www.lls.org/graphics/National/CortesslidesFINAL.pdf CML Information for the Newly Diagnosed - Part 2 no CML Information for the Newly Diagnosed - Part 2 October 19, 2010 CML Information for the Newly Diagnosed - Part 2 (Q&A) This program featured Jorge Cortes, MD, D.B. Lane Cancer Research Distinguished Professor for Leukemia Research, Deputy Chairman, Section Chief of AML & CML, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston TX. This program was sponsored by The Leukemia & Lymphoma Society and was supported by grants from Novartis Oncology and Bristol-Myers Squibb. Program slides: http://www.lls.org/graphics/National/CortesslidesFINAL.pdf http://lls.hipcast.com/deluge/ddcc046d-6dff-f931-251a-b492c875ecd7.mp3 b082d068-ce71-7220-88af-b9bd5a888764 Fri, 05 Nov 2010 14:55:08 GMT 00:34:01 The Leukemia & Lymphoma Society October 19, 2010 CML Information for the Newly Diagnosed - Part 1 (Presentation) This program featured Jorge Cortes, MD, D.B. Lane Cancer Research Distinguished Professor for Leukemia Research, Deputy Chairman, Section Chief of AML & CML, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston TX. This program was sponsored by The Leukemia & Lymphoma Society and was supported by grants from Novartis Oncology and Bristol-Myers Squibb. Program slides: http://www.lls.org/graphics/National/CortesslidesFINAL.pdf CML Information for the Newly Diagnosed - Part 1 no CML Information for the Newly Diagnosed - Part 1 October 19, 2010 CML Information for the Newly Diagnosed - Part 1 (Presentation) This program featured Jorge Cortes, MD, D.B. Lane Cancer Research Distinguished Professor for Leukemia Research, Deputy Chairman, Section Chief of AML & CML, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston TX. This program was sponsored by The Leukemia & Lymphoma Society and was supported by grants from Novartis Oncology and Bristol-Myers Squibb. Program slides: http://www.lls.org/graphics/National/CortesslidesFINAL.pdf http://lls.hipcast.com/deluge/a332e4ad-2a3b-5b9f-e5c9-33a60438d583.mp3 a173bfa4-e51d-a24c-375f-7ec61c1f91a6 Wed, 03 Nov 2010 19:32:53 GMT 00:56:55 The Leukemia & Lymphoma Society Getting the Answers You Need: Fatigue and Other Cancer Treatment October 20, 2010 This young adult program featured Owen Applequist, NHL/Hodgkin Survivor, Michael G. Douvas, MD, Assistant Professor of Medicine, Hematology/Oncology Division, University of Virginia Health System; Jeanne M. Erickson, PhD, RN, AOCN, Robert's Scholar, Assistant Professor, University of Virginia School of Nursing and Clare Karten, MS, Sr. Director of Mission Education, The Leukemia & Lymphoma Society. This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Genentech and Biogen Idec. Download the program slides that accompany this event here: http://www.lls.org/graphics/National/YAconnectPPTslides1020FINAL.pdf Getting the Answers You Need: Fatigue and Other Cancer Treatment no Getting the Answers You Need: Fatigue and Other Cancer Treatment Getting the Answers You Need: Fatigue and Other Cancer Treatment October 20, 2010 This young adult program featured Owen Applequist, NHL/Hodgkin Survivor, Michael G. Douvas, MD, Assistant Professor of Medicine, Hematology/Oncology Division, University of Virginia Health System; Jeanne M. Erickson, PhD, RN, AOCN, Robert's Scholar, Assistant Professor, University of Virginia School of Nursing and Clare Karten, MS, Sr. Director of Mission Education, The Leukemia & Lymphoma Society. This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Genentech and Biogen Idec. Download the program slides that accompany this event here: http://www.lls.org/graphics/National/YAconnectPPTslides1020FINAL.pdf http://lls.hipcast.com/deluge/6c768f9e-e4dd-38fb-e51d-2028d0285619.mp3 a0806e4e-70eb-1358-2033-806f35f2c497 Fri, 16 Jul 2010 18:17:22 GMT 00:51:40 The Leukemia & Lymphoma Society June 30, 2010 Navigating Employment and Insurance This young adult program featured Jeremy Katzman, Leukemia Survivor, Cyndy Sotomayor, Lymphoma Survivor, Joanna L. Fawzy Morales, Esq. Director, Cancer Legal Resource Center, Adjunct Professor of Law, Loyola Law School and Gina Russo, LCSW, Director, Information Resource Center, The Leukemia & Lymphoma Society. This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Genentech and Biogen Idec. Program slides: http://www.leukemia-lymphoma.org/graphics/National/Resources_slides_6_28_10_with_footer.ppt A Young Adult Webcast no Navigating Employment and Insurance June 30, 2010 Navigating Employment and Insurance This young adult program featured Jeremy Katzman, Leukemia Survivor, Cyndy Sotomayor, Lymphoma Survivor, Joanna L. Fawzy Morales, Esq. Director, Cancer Legal Resource Center, Adjunct Professor of Law, Loyola Law School and Gina Russo, LCSW, Director, Information Resource Center, The Leukemia & Lymphoma Society. This program was sponsored by The Leukemia & Lymphoma Society and supported by a grant from Genentech and Biogen Idec. Program slides: http://www.leukemia-lymphoma.org/graphics/National/Resources_slides_6_28_10_with_footer.ppt http://lls.hipcast.com/deluge/980fc7cd-1075-a86f-61da-6aac0ac2ac77.mp3 e16c96b2-5e0a-09c8-60a1-8c4dc73243ed Fri, 09 Jul 2010 15:54:57 GMT 00:59:54 The Leukemia & Lymphoma Society June 22, 2010 - Part 2 Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine & Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia & Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.   This program was sponsored by The Leukemia & Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen. Partners in Progress: An Expert Panel Discussion - Part 2 no Partners in Progress: An Expert Panel Discussion - Part 2 June 22, 2010 - Part 2 Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine & Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia & Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.   This program was sponsored by The Leukemia & Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen. http://lls.hipcast.com/deluge/aebb9375-46e9-19fc-8536-b44daa0d4e65.mp3 9e9045dc-01f2-3d1b-7831-4f3020596311 Fri, 09 Jul 2010 15:53:26 GMT 00:53:18 The Leukemia & Lymphoma Society June 22, 2010 - Part 1 Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine & Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia & Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.   This program was sponsored by The Leukemia & Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen. Partners in Progress: An Expert Panel Discussion - Part 1 no Partners in Progress: An Expert Panel Discussion - Part 1 June 22, 2010 - Part 1 Partners in Progress: An Expert Panel Discussion on Advancing Therapies for Blood Cancers This program featured Gail J. Roboz, MD, Director, Leukemia Program, Associate Professor of Medicine and Maria Baldo, MS, PA-C, Senior Physician Assistant, Leukemia Service both from Weill Cornell Medical College of Cornell University in New York and Stuart L. Goldberg, MD, Chief, Division of Leukemia, John Theurer Cancer Center, Hackensack University Medical Center, Associate Clinical Professor of Medicine, University of Medicine & Dentistry of New Jersey and Louis J. DeGennaro, PhD, Executive Vice President and Chief Mission Officer, The Leukemia & Lymphoma Society, White Plains, New York and John J. Hughes, MDS Survivor and Clinical Trial Participant from Bayonne, New Jersey.   This program was sponsored by The Leukemia & Lymphoma Society and supported by an educational grant from Genentech and Biogen Idec and also supported by an educational donation from Amgen. http://lls.hipcast.com/deluge/2b92886f-90b9-50f5-3401-517ec2b923c2.mp3 eb31ff8b-5418-acf7-cb00-a7e3c6fb01e7 Fri, 14 May 2010 18:21:17 GMT 00:54:30 The Leukemia & Lymphoma Society April 29, 2010 CML: Understanding Your Treatment Options This program featured David L. Porter, MD, Professor of Medicine, University of Pennsylvania School of Medicine, Director, Blood and Marrow Transplantation, Hospital of the University of Pennsylvania, Philadelphia, PA. 

This program was sponsored by The Leukemia & Lymphoma Society and was supported by a grant from Novartis Oncology. CML: Understanding Your Treatment Options no CML: Understanding Your Treatment Options April 29, 2010 CML: Understanding Your Treatment Options This program featured David L. Porter, MD, Professor of Medicine, University of Pennsylvania School of Medicine, Director, Blood and Marrow Transplantation, Hospital of the University of Pennsylvania, Philadelphia, PA. 

This program was sponsored by The Leukemia & Lymphoma Society and was supported by a grant from Novartis Oncology. http://lls.hipcast.com/deluge/e5e20ad6-eddd-8ce1-4159-8d1ab0448d5a.mp3 9e2badef-da4c-572e-7e6a-4014ae00f025 Fri, 02 Oct 2009 14:54:12 GMT 00:54:58 The Leukemia & Lymphoma Society September 15, 2009 CML: What Every Newly Diagnosed Patient Needs to Know This program featured Jorge Cortes, MD, Professor of Medicine, Chief, CML Section, Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX. This program was sponsored by The Leukemia & Lymphoma Society and was supported by a grant from Novartis Oncology. CML: What Every Newly Diagnosed Patient Needs to Know no CML: What Every Newly Diagnosed Patient Needs to Know September 15, 2009 CML: What Every Newly Diagnosed Patient Needs to Know This program featured Jorge Cortes, MD, Professor of Medicine, Chief, CML Section, Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX. This program was sponsored by The Leukemia & Lymphoma Society and was supported by a grant from Novartis Oncology. http://lls.hipcast.com/deluge/70b561b3-e5de-3010-8b37-84371bbda5cf.mp3